Nasdaq · CIK 0001572616
GUTS FRACTYL HEALTH, INC.
Insider trading from SEC Form 4. Last filing 26 d ago. Close $4.42 on Oct 9, 2026, +4% from the 52-week low and -84% from the high.
Last 90 days
Net insider value
+$40k
more bought than sold
Buys
1
$40k by 1 insider
Sells
0
$0 by 0 insiders
Insiders on file
15
with a Form 4 at this company
Price and insider trades, last year
GUTSOct 9, 2026 · close 4.42
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at FRACTYL HEALTH, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | William Bradley director buy | $40k 64,516 shares | +76% | - | |
| 33Weak | Harith Rajagopalan Chief Executive Officer buy | $20k 10,416 shares | +2% | +120% from low-31% from high | |
| 44Moderate | Kelly Ann Barnes director buy | $40k 31,000 shares | - | - | |
| 38Weak | Ajay Royan director, owner buy | $23k 17,901 shares | - | - | |
| 38Weak | William Bradley director buy | $20k 16,129 shares | - | - | |
| 38Weak | Samuel Conaway director buy | $9,964 8,550 shares | - | - | |
| 38Weak | Amy W Schulman director buy | $9,964 8,550 shares | - | - | |
| 12Weak | Jay David Caplan President, Chief Product Off. sell | $82k 43,818 shares | -25% | - | |
| 15Weak | Harith Rajagopalan Chief Executive Officer sell | $206k 111,920 shares | -22% | - | |
| 34Weak | Jay David Caplan President, Chief Product Off. sell | $159k 64,197 shares | -29% | - | |
| 36Weak | Harith Rajagopalan Chief Executive Officer sell | $238k 96,517 shares | -16% | - |
Transactions
The last 48 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | William Bradley director | POpen-market purchase Common Stock | +64,516 | $0.62 | $40k | 149,138 | 26 d ago |
| Jan 12, 2026 | Weber Lara Smith Chief Financial Officer | AGrant or award Stock Optionderivative | +1,036,800 | $0.00 | $0 | 1,036,800 | Jan 14, 2026 |
| Dec 15, 2025 | Harith Rajagopalan Chief Executive Officer | AGrant or award Stock Option (right to buy)derivative | +2,486,302 | $0.00 | $0 | 2,486,302 | Dec 17, 2025 |
| Dec 15, 2025 | Sarah Toomey General Counsel | AGrant or award Stock Option (right to buy)derivative | +743,913 | $0.00 | $0 | 743,913 | Dec 17, 2025 |
| Dec 15, 2025 | Jay David Caplan President, Chief Product Off. | AGrant or award Stock Option (right to buy)derivative | +845,226 | $0.00 | $0 | 845,226 | Dec 17, 2025 |
| Dec 4, 2025 | Harith Rajagopalan Chief Executive Officer | POpen-market purchase Common Stock | +10,416 | $1.92 | $20k | 501,745 | Dec 8, 2025 |
| Sep 2, 2025 | Ian Sheffield director | AGrant or award Stock Optionderivative | +45,000 | $0.00 | $0 | 45,000 | Sep 4, 2025 |
| Sep 2, 2025 | Christopher Charles Thompson director | AGrant or award Stock Optionderivative | +45,000 | $0.00 | $0 | 45,000 | Sep 4, 2025 |
| Jun 11, 2025 | Ajay Royan director, owner | AGrant or award Stock Optionderivative | +22,500 | $0.00 | $0 | 22,500 | Jun 13, 2025 |
| Jun 11, 2025 | Clive Meanwell director | AGrant or award Stock Optionderivative | +22,500 | $0.00 | $0 | 22,500 | Jun 13, 2025 |
| Jun 11, 2025 | Amy W Schulman director | AGrant or award Stock Optionderivative | +22,500 | $0.00 | $0 | 22,500 | Jun 13, 2025 |
| Jun 11, 2025 | Marc Elia director | AGrant or award Stock Optionderivative | +22,500 | $0.00 | $0 | 22,500 | Jun 13, 2025 |
| Jun 11, 2025 | Samuel Conaway director | AGrant or award Stock Optionderivative | +22,500 | $0.00 | $0 | 22,500 | Jun 13, 2025 |
| Jun 11, 2025 | Kelly Ann Barnes director | AGrant or award Stock Optionderivative | +22,500 | $0.00 | $0 | 22,500 | Jun 13, 2025 |
| Jun 11, 2025 | William Bradley director | AGrant or award Stock Optionderivative | +22,500 | $0.00 | $0 | 22,500 | Jun 13, 2025 |
| Mar 14, 2025 | Kelly Ann Barnes director | POpen-market purchase Common Stock | +31,000 | $1.30 | $40k | 31,000 | Mar 18, 2025 |
| Mar 14, 2025 | Ajay Royan director, owner | POpen-market purchase Common Stock | +17,901 | $1.28 | $23k | 17,901 | Mar 18, 2025 |
| Mar 13, 2025 | William Bradley director | POpen-market purchase Common Stock | +16,129 | $1.26 | $20k | 16,129 | Mar 17, 2025 |
| Mar 13, 2025 | Samuel Conaway director | POpen-market purchase Common Stock | +8,550 | $1.17 | $9,964 | 8,550 | Mar 17, 2025 |
| Mar 13, 2025 | Amy W Schulman director | POpen-market purchase Common Stock | +8,550 | $1.17 | $9,964 | 8,550 | Mar 17, 2025 |
| Feb 27, 2025 | Timothy Kieffer Chief Scientific Officer | AGrant or award Stock Option (right to buy)derivative | +169,700 | $0.00 | $0 | 169,700 | Mar 3, 2025 |
| Feb 27, 2025 | Sarah Toomey General Counsel | AGrant or award Stock Option (right to buy)derivative | +166,200 | $0.00 | $0 | 166,200 | Mar 3, 2025 |
| Feb 27, 2025 | Harith Rajagopalan Chief Executive Officer | AGrant or award Stock Option (right to buy)derivative | +571,491 | $0.00 | $0 | 571,491 | Mar 3, 2025 |
| Feb 27, 2025 | Lisa Davidson Chief Financial Officer | AGrant or award Stock Option (right to buy)derivative | +174,700 | $0.00 | $0 | 174,700 | Mar 3, 2025 |
| Feb 27, 2025 | Jay David Caplan President, Chief Product Off. | AGrant or award Stock Option (right to buy)derivative | +179,700 | $0.00 | $0 | 179,700 | Mar 3, 2025 |
| Feb 27, 2025 | Harith Rajagopalan Chief Executive Officer | AGrant or award Stock Option (right to buy)derivative | +261,540 | $0.00 | $0 | 261,540 | Mar 3, 2025 |
| Feb 27, 2025 | Jay David Caplan President, Chief Product Off. | AGrant or award Stock Option (right to buy)derivative | +104,400 | $0.00 | $0 | 104,400 | Mar 3, 2025 |
| Feb 27, 2025 | Sarah Toomey General Counsel | AGrant or award Stock Option (right to buy)derivative | +79,380 | $0.00 | $0 | 79,380 | Mar 3, 2025 |
| Feb 27, 2025 | Timothy Kieffer Chief Scientific Officer | AGrant or award Stock Option (right to buy)derivative | +35,280 | $0.00 | $0 | 35,280 | Mar 3, 2025 |
| Feb 27, 2025 | Lisa Davidson Chief Financial Officer | AGrant or award Stock Option (right to buy)derivative | +91,500 | $0.00 | $0 | 91,500 | Mar 3, 2025 |
| Jan 30, 2025 | Harith Rajagopalan Chief Executive Officer | MOption exercise Common Stock10b5-1 | +20,948 | $1.70 | $36k | 512,277 | Feb 3, 2025 |
| Jan 30, 2025 | Jay David Caplan President, Chief Product Off. | MOption exercise Common Stock10b5-1 | +21,472 | $1.70 | $37k | 175,016 | Feb 3, 2025 |
| Jan 30, 2025 | Harith Rajagopalan Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -20,948 | $1.95 | $41k | 491,329 | Feb 3, 2025 |
| Jan 30, 2025 | Jay David Caplan President, Chief Product Off. | SOpen-market sale Common Stock10b5-1 | -21,472 | $1.95 | $42k | 153,544 | Feb 3, 2025 |
| Jan 31, 2025 | Harith Rajagopalan Chief Executive Officer | MOption exercise Common Stock10b5-1 | +90,972 | $1.70 | $155k | 582,301 | Feb 3, 2025 |
| Jan 31, 2025 | Jay David Caplan President, Chief Product Off. | MOption exercise Common Stock10b5-1 | +22,346 | $1.70 | $38k | 175,890 | Feb 3, 2025 |
| Jan 31, 2025 | Harith Rajagopalan Chief Executive Officer | SOpen-market sale Common Stock10b5-1 | -90,972 | $1.82 | $165k | 491,329 | Feb 3, 2025 |
| Jan 31, 2025 | Jay David Caplan President, Chief Product Off. | SOpen-market sale Common Stock10b5-1 | -22,346 | $1.81 | $40k | 153,544 | Feb 3, 2025 |
| Jan 30, 2025 | Jay David Caplan President, Chief Product Off. | MOption exercise Stock Optionderivative10b5-1 | -21,472 | $0.00 | $0 | 40,270 | Feb 3, 2025 |
| Jan 30, 2025 | Harith Rajagopalan Chief Executive Officer | MOption exercise Stock Optionderivative10b5-1 | -20,948 | $0.00 | $0 | 102,536 | Feb 3, 2025 |
| Jan 31, 2025 | Jay David Caplan President, Chief Product Off. | MOption exercise Stock Optionderivative10b5-1 | -22,346 | $0.00 | $0 | 17,924 | Feb 3, 2025 |
| Jan 31, 2025 | Harith Rajagopalan Chief Executive Officer | MOption exercise Stock Optionderivative10b5-1 | -90,972 | $0.00 | $0 | 11,564 | Feb 3, 2025 |
| Nov 10, 2024 | Jay David Caplan President, Chief Product Off. | MOption exercise Common Stock | +187,257 | $0.00 | $0 | 217,741 | Nov 13, 2024 |
| Nov 10, 2024 | Harith Rajagopalan Chief Executive Officer | MOption exercise Common Stock | +216,924 | $0.00 | $0 | 587,846 | Nov 13, 2024 |
| Nov 11, 2024 | Jay David Caplan President, Chief Product Off. | SOpen-market sale Common Stock | -64,197 | $2.47 | $159k | 153,544 | Nov 13, 2024 |
| Nov 11, 2024 | Harith Rajagopalan Chief Executive Officer | SOpen-market sale Common Stock | -96,517 | $2.47 | $238k | 491,329 | Nov 13, 2024 |
| Nov 10, 2024 | Jay David Caplan President, Chief Product Off. | MOption exercise Restricted Stock Unitderivative | -187,257 | $0.00 | $0 | 0 | Nov 13, 2024 |
| Nov 10, 2024 | Harith Rajagopalan Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | -216,924 | $0.00 | $0 | 0 | Nov 13, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- William Bradleydirector
- Kelly Ann Barnesdirector
- Jay David CaplanPresident, Chief Product Off.
- Samuel Conawaydirector
- Lisa DavidsonChief Financial Officer
- Marc Eliaceo, officer, director, other
- Timothy KiefferChief Scientific Officer
- Clive Meanwelldirector, chair, officer
- Harith RajagopalanChief Executive Officer
- Ajay Royandirector, owner
- Amy W Schulmanowner, director
- Ian Sheffielddirector
- Weber Lara SmithChief Financial Officer
- Christopher Charles Thompsondirector
- Sarah ToomeyGeneral Counsel
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.